Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1944 1
1946 1
1947 1
1956 1
1958 3
1961 1
1962 1
1965 3
1966 3
1967 4
1968 2
1969 6
1970 1
1971 7
1972 1
1973 2
1975 1
1976 1
1977 4
1978 1
1979 4
1980 4
1981 1
1982 1
1983 5
1984 9
1985 4
1986 1
1987 2
1988 3
1989 5
1990 2
1991 3
1992 3
1993 1
1994 6
1995 7
1996 5
1997 4
1998 1
1999 4
2000 6
2001 9
2002 9
2003 5
2004 5
2005 5
2006 4
2007 4
2008 6
2009 5
2013 1
2014 1
2016 3
2017 1
2019 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy.
Kober C, Roewe J, Schmees N, Roese L, Roehn U, Bader B, Stoeckigt D, Prinz F, Gorjánácz M, Roider HG, Olesch C, Leder G, Irlbacher H, Lesche R, Lefranc J, Oezcan-Wahlbrink M, Batra AS, Elmadany N, Carretero R, Sahm K, Oezen I, Cichon F, Baumann D, Sadik A, Opitz CA, Weinmann H, Hartung IV, Kreft B, Offringa R, Platten M, Gutcher I. Kober C, et al. Among authors: weinmann h. J Immunother Cancer. 2023 Nov;11(11):e007495. doi: 10.1136/jitc-2023-007495. J Immunother Cancer. 2023. PMID: 37963637 Free PMC article.
Bromodomains and their pharmacological inhibitors.
Gallenkamp D, Gelato KA, Haendler B, Weinmann H. Gallenkamp D, et al. Among authors: weinmann h. ChemMedChem. 2014 Mar;9(3):438-64. doi: 10.1002/cmdc.201300434. Epub 2014 Feb 4. ChemMedChem. 2014. PMID: 24497428 Review.
Contrast media: future aspects.
Weinmann HJ, Platzek J, Schirmer H, Pietsch H, Carretero J, Harto J, Medina J, Riefke B, Martín J. Weinmann HJ, et al. Eur Radiol. 2005 Nov;15 Suppl 4:D70-3. doi: 10.1007/s10406-005-0119-4. Eur Radiol. 2005. PMID: 16479651 Review.
Tissue-specific MR contrast agents.
Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H. Weinmann HJ, et al. Eur J Radiol. 2003 Apr;46(1):33-44. doi: 10.1016/s0720-048x(02)00332-7. Eur J Radiol. 2003. PMID: 12648800 Review.
Gallium-67/stable gadolinium antagonism.
Wiggins JR, Goldstein HA, Weinmann HJ. Wiggins JR, et al. Among authors: weinmann hj. J Nucl Med. 1991 Sep;32(9):1830-2. J Nucl Med. 1991. PMID: 1880591 Free article. No abstract available.
Asymmetric organocatalysis.
Jaroch S, Weinmann H, Zeitler K. Jaroch S, et al. Among authors: weinmann h. ChemMedChem. 2007 Sep;2(9):1261-4. doi: 10.1002/cmdc.200700109. ChemMedChem. 2007. PMID: 17607798 Review. No abstract available.
Small-molecule modulators for epigenetics targets.
Knapp S, Weinmann H. Knapp S, et al. Among authors: weinmann h. ChemMedChem. 2013 Nov;8(11):1885-91. doi: 10.1002/cmdc.201300344. Epub 2013 Oct 14. ChemMedChem. 2013. PMID: 24127276
Drug discovery process for kinase inhibitors.
Weinmann H, Metternich R. Weinmann H, et al. Chembiochem. 2005 Mar;6(3):455-9. doi: 10.1002/cbic.200500034. Chembiochem. 2005. PMID: 15742380 No abstract available.
[Antiepileptics-review--2].
Weinmann HM, Windorfer A. Weinmann HM, et al. Fortschr Med. 1977 Sep 15;95(34):2059-63. Fortschr Med. 1977. PMID: 903069 German. No abstract available.
188 results